Finanza

CinCor Pharma, Inc.: Oppenheimer mantiene la raccomandazione Buy

This content has been archived. It may no longer be relevant

CinCor Pharma, Inc.: Oppenheimer mantiene la raccomandazione Buy

CinCor Pharma Oppenheimer


FIMA2681# 2022-08-08T21:01:12+02:00

Show More